{"id":1157,"date":"2021-06-06T20:59:24","date_gmt":"2021-06-06T18:59:24","guid":{"rendered":"https:\/\/imi-pharma.com\/?page_id=1157"},"modified":"2021-06-15T11:12:01","modified_gmt":"2021-06-15T09:12:01","slug":"onkologji","status":"publish","type":"page","link":"https:\/\/imi-pharma.com\/english\/?page_id=1157","title":{"rendered":"Onkologji"},"content":{"rendered":"

[vc_row][vc_column width=”1\/2″][vc_custom_heading text=”Kanceri kolorektal”][vc_column_text]<\/p>\n

Kishte mbi 1.8 milion raste t\u00eb reja t\u00eb kancerit kolorektal (CRC) \u00e7do vit. Si kanceri i tret\u00eb m\u00eb i diagnostikuar m\u00eb shpesh, \u00ebsht\u00eb gjithashtu shkaku i kat\u00ebrt kryesor i vdekjeve t\u00eb lidhura me kancerin. Numri global i rasteve CRC pritet t\u00eb rritet me 60% n\u00eb m\u00eb shum\u00eb se 2.2 milion raste t\u00eb reja dhe af\u00ebrsisht 1.1 milion vdekje n\u00eb vit deri n\u00eb 2030.<\/p>\n

Depistimi \u00ebsht\u00eb nj\u00eb metod\u00eb kryesore parandaluese p\u00ebr CRC pasi mund t\u00eb gjej\u00eb polipe parakanceroze (rritje anormale) dhe t’i heq ato para se t\u00eb b\u00ebhen kanceroze. Diagnoza e hershme rrit ndjesh\u00ebm gjasat e trajtimit t\u00eb suksessh\u00ebm. Aktualisht, deri n\u00eb 60% t\u00eb vdekjeve nga CRC mund t\u00eb parandalohen me depistimin. Sidoqoft\u00eb, vet\u00ebm 39% e rasteve t\u00eb CRC zbulohen n\u00eb nj\u00eb faz\u00eb t\u00eb hershme ku kirurg\u00ebt mund t\u00eb jen\u00eb ende n\u00eb gjendje t\u00eb heqin indet malinje para se t\u00eb prekin pjes\u00ebt e tjera t\u00eb trupit. N\u00eb nj\u00eb t\u00eb kat\u00ebrt\u00ebn e rasteve t\u00eb reja, kjo p\u00ebrhapje n\u00eb pjes\u00eb t\u00eb tjera t\u00eb trupit, ose metastazimi, tashm\u00eb ka ndodhur<\/p>\n

CRC metastatike (mCRC) \u00ebsht\u00eb kanceri q\u00eb filloi n\u00eb zorr\u00eb t\u00eb trash\u00eb ose rektum, por q\u00eb at\u00ebher\u00eb \u00ebsht\u00eb p\u00ebrhapur n\u00eb nj\u00eb organ tjet\u00ebr. Gjaku nga zorra e trash\u00eb shkon drejtp\u00ebrdrejt n\u00eb m\u00ebl\u00e7i, e cila shpesh \u00ebsht\u00eb organi i par\u00eb q\u00eb preket kur s\u00ebmundja p\u00ebrhapet. Nyjet limfatike, t\u00eb cilat jan\u00eb af\u00ebr zorr\u00ebve, jan\u00eb gjithashtu t\u00eb prekshme n\u00eb k\u00ebt\u00eb faz\u00eb.<\/p>\n

Ashtu si me kanceret e tjer\u00eb, trajtimi p\u00ebr mCRC varet nga sa e avancuar \u00ebsht\u00eb s\u00ebmundja, organet e prekura dhe sh\u00ebndeti i pacientit. Nj\u00eb p\u00ebrzierje e trajtimeve t\u00eb ndryshme \u00ebsht\u00eb e zakonshme. Aktualisht opsionet p\u00ebrfshijn\u00eb kimioterapi dhe terapi t\u00eb reja q\u00eb synojn\u00eb n\u00eb m\u00ebnyr\u00eb specifike qelizat kancerogjene<\/p>\n

[\/vc_column_text][\/vc_column][vc_column width=”1\/2″][vc_custom_heading text=”Colorectal Cancer”][vc_column_text]<\/p>\n

There were over 1.8 million new cases of colorectal cancer (CRC) yearly. As the third most commonly diagnosed cancer, it is also the fourth leading cause of cancer-related death. The global number of CRC cases is expected to increase by 60% to more than 2.2 million new cases and approximately 1.1 million deaths annually by 2030.<\/p>\n

Screening is a key prevention method for CRC as it can find precancerous polyps (abnormal growths) and remove them before they become cancerous. Early diagnosis significantly increases the likelihood of successful treatment. Currently, up to 60% of CRC deaths could be prevented with screening. However, only 39% of CRC cases are detected at an early stage where surgeons may still be able to remove malignant tissue before it affects other parts of the body. In a quarter of new cases, this spread to other parts of the body, or metastasizing, has already happened<\/p>\n

Metastatic CRC (mCRC) is cancer that started in the large intestine or rectum but has since spread to another organ. Blood from the colon goes directly to the liver, which is often the first organ affected as the disease spreads. The lymph nodes, which are near the bowel, are also vulnerable at this stage.<\/p>\n

As with other cancers, treatment for mCRC depends on how advanced the disease is, the organs affected, and the health of the patient. A mixture of different treatments is common. Options currently include chemotherapy and newer therapies that specifically target cancer cells<\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator][\/vc_column][\/vc_row][vc_row][vc_column][home_blog style=”grid” posts_per_page=”25″ dynamic_from_where=”cat” dynamic_cat=”20″][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column width=”1\/2″][vc_custom_heading text=”Kanceri kolorektal”][vc_column_text] Kishte mbi 1.8 milion raste t\u00eb reja t\u00eb kancerit kolorektal (CRC) \u00e7do vit. Si kanceri i tret\u00eb m\u00eb i diagnostikuar m\u00eb shpesh, \u00ebsht\u00eb gjithashtu shkaku i kat\u00ebrt kryesor i vdekjeve t\u00eb lidhura me kancerin. Numri global i rasteve CRC pritet t\u00eb rritet me 60% n\u00eb m\u00eb shum\u00eb se 2.2 milion raste […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1157","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/pages\/1157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1157"}],"version-history":[{"count":3,"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/pages\/1157\/revisions"}],"predecessor-version":[{"id":1382,"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/pages\/1157\/revisions\/1382"}],"wp:attachment":[{"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}